Literature DB >> 19869893

THE ACCUMULATION OF IRON IN TUBERCULOUS AREAS.

V Menkin1, M F Menkin.   

Abstract

Repeated daily intravenous injections of ferric chloride solution are followed by an accumulation of iron in tuberculous areas of lungs. The iron accumulates in the caseous areas of tubercles and is demonstrable by the Prussian blue reaction. Quantitative determinations corroborate these results and show that the iron content of lung tissue in tuberculous animals injected with ferric chloride exceeds that in normal animals injected with this salt, as well as that in non-injected tuberculous animals.

Entities:  

Year:  1931        PMID： 19869893      PMCID： PMC2132030          DOI： 10.1084/jem.53.6.919

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  4 in total

1.  STUDIES ON INFLAMMATION : II. A MEASURE OF THE PERMEABILITY OF CAPILLARIES IN AN INFLAMED AREA.

Authors:  V Menkin; M F Menkin
Journal:  J Exp Med       Date:  1930-01-31       Impact factor: 14.307

2.  THE DISTRIBUTION OF TRYPAN-RED TO THE TISSUES AND VESSELS OF THE EYE AS INFLUENCED BY CONGESTION AND EARLY INFLAMMATION.

Authors:  P A Lewis
Journal:  J Exp Med       Date:  1916-05-01       Impact factor: 14.307

3.  STUDIES ON INFLAMMATION : III. FIXATION OF A METAL IN INFLAMED AREAS.

Authors:  V Menkin
Journal:  J Exp Med       Date:  1930-05-31       Impact factor: 14.307

4.  STUDIES ON INFLAMMATION : I. FIXATION OF VITAL DYES IN INFLAMED AREAS.

Authors:  V Menkin
Journal:  J Exp Med       Date:  1929-07-31       Impact factor: 14.307
  4 in total
  2 in total

1.  THE ACCUMULATION OF IRON IN TUBERCULOUS AREAS : II. SURVIVAL TIME OF TUBERCULOUS RABBITS INJECTED WITH FERRIC CHLORIDE.

Authors:  V Menkin
Journal:  J Exp Med       Date:  1932-01-01       Impact factor: 14.307

2.  THE ACCUMULATION OF IRON IN TUBERCULOUS AREAS : IV. THE EFFECT OF FERRIC CHLORIDE ON THE COURSE OF TUBERCULOSIS IN REINFECTED RABBITS.

Authors:  V Menkin
Journal:  J Exp Med       Date:  1934-09-30       Impact factor: 14.307
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.